|
UK to Begin Negotiating Value-Based Pricing Scheme for Brand Drugs Next Month
Negotiations on the future of the UK’s pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement from the UK’s Department of Health and the Association of the British Pharmaceutical Industry (ABPI).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives